These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38863724)

  • 1. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
    Milosevic V; Östman A
    Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAFs and T cells interplay: The emergence of a new arena in cancer combat.
    Chen M; Chen F; Gao Z; Li X; Hu L; Yang S; Zhao S; Song Z
    Biomed Pharmacother; 2024 Aug; 177():117045. PubMed ID: 38955088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
    Mhaidly R; Mechta-Grigoriou F
    Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer Therapy.
    Allam A; Yakou M; Pang L; Ernst M; Huynh J
    Front Immunol; 2021; 12():767939. PubMed ID: 34858425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between cancer-associated fibroblasts and immune cells in cancer.
    An Y; Liu F; Chen Y; Yang Q
    J Cell Mol Med; 2020 Jan; 24(1):13-24. PubMed ID: 31642585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts.
    Arpinati L; Scherz-Shouval R
    Trends Cancer; 2023 May; 9(5):421-443. PubMed ID: 36870916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
    Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
    Front Immunol; 2021; 12():656364. PubMed ID: 34122412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
    Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
    Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
    Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
    Front Immunol; 2021; 12():671595. PubMed ID: 34305902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
    Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
    J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
    Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
    Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity.
    Koppensteiner L; Mathieson L; O'Connor RA; Akram AR
    Front Immunol; 2022; 13():887380. PubMed ID: 35479076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizing Radiation Curtails Immunosuppressive Effects From Cancer-Associated Fibroblasts on Dendritic Cells.
    Berzaghi R; Tornaas S; Lode K; Hellevik T; Martinez-Zubiaurre I
    Front Immunol; 2021; 12():662594. PubMed ID: 34177901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.